{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:18:01Z","timestamp":1794590281692,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.transci.2024.103963","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:53:29Z","timestamp":1718974409000},"page":"103963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Irregular red blood cell antibodies, abnormal hemoglobin and dangerous universal blood donor insights from a public blood center in a Brazilian metropolitan area"],"prefix":"10.1016","volume":"63","author":[{"given":"Laiane da Silva","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Eduardo Soares","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Luiza Oliveira","family":"Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Ferreira Pontes","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Ferreira Pontes","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Ferreira","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.103963_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100593","article-title":"Review of current transfusion therapy and blood banking practices","volume":"38","author":"Storch","year":"2019","journal-title":"Blood Rev"},{"issue":"12","key":"10.1016\/j.transci.2024.103963_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/vox.13546","article-title":"Degree of blood safety of voluntary non-remunerated versus replacement blood donations: a multi-centre study of the large cohort of blood donors from two provinces of Pakistan","volume":"118","author":"Jamal","year":"2023","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103963_bib3","unstructured":"World Health Organization. Blood safety and availability; 2023. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability\u3009."},{"key":"10.1016\/j.transci.2024.103963_bib4","unstructured":"World Health Organization. Global status report on blood safety and availability; 2021. \u3008https:\/\/iris.who.int\/bitstream\/handle\/10665\/356165\/9789240051683-eng.pdf\u3009."},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/ijmr.IJMR_296_19","article-title":"Prevalence of red blood cell antibodies in whole blood donors: a single-centre experience in north India","volume":"152","author":"Solanki","year":"2020","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.transci.2024.103963_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/gjtm.gjtm_60_21","article-title":"Prevalence of unexpected red cell antibodies in healthy donor population in a tertiary care center in South Kerala","volume":"6","author":"Gayathri","year":"2021","journal-title":"Glob J Transfus Med"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.transci.2014.03.004","article-title":"Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population","volume":"50","author":"Garg","year":"2014","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-3148.2006.00661.x","article-title":"Red blood cells from donors with sickle cell trait: a safety issue for transfusion?","volume":"16","author":"Amar","year":"2006","journal-title":"Transfus Med"},{"issue":"9","key":"10.1016\/j.transci.2024.103963_bib9","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/trf.13209","article-title":"Simultaneous blood donor screening for abnormal hemoglobin levels and glycated hemoglobin (HbA1c) by high-performance liquid chromatography","volume":"55","author":"Levi","year":"2015","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.htct.2020.11.009","article-title":"Hemoglobin S identification in blood donors: a cross section of prevalence","volume":"44","author":"Kroger","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjhh.2016.05.007","article-title":"Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais","volume":"38","author":"Godin","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"2-3","key":"10.1016\/j.transci.2024.103963_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1020-49892003000200016","article-title":"Trends in the profile of blood donors at a large blood center in the city of S\u00e3o Paulo, Brazil","volume":"13","author":"Gon\u00e7alez","year":"2003","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1537-2995.2009.02529.x","article-title":"Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007\u20132008","volume":"50","author":"Carneiro-Proietti","year":"2010","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.transci.2024.103963_bib14","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1537-2995.2005.00575.x","article-title":"Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in S\u00e3o Paulo, Brazil","volume":"45","author":"Barreto","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103963_bib15","unstructured":"Brasil. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Produ\u00e7\u00e3o hemoter\u00e1pica no Brasil; 2022. \u3008https:\/\/app.powerbi.com\/view?r=eyJrIjoiMWM4MDQzNDMtYjZjZC00ZTBhLWFkOTctODdiZjE2ODQ4YTJkIiwidCI6ImI2N2FmMjNmLWMzZjMtNGQzNS04MGM3LWI3MDg1ZjVlZGQ4MSJ9\u3009."},{"key":"10.1016\/j.transci.2024.103963_bib16","unstructured":"Brasil. Portaria N\u00ba 158, de 4 de fevereiro de 2016; 2016. \u3008https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2016\/prt0158_04_02_2016.html\u3009."},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.htct.2019.03.007","article-title":"Seroprevalence of transfusion-transmissible infectious diseases at a hemotherapy service located in southwest Bahia, Brazil","volume":"41","author":"Rebou\u00e7as","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"issue":"5","key":"10.1016\/j.transci.2024.103963_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1179\/1607845412Y.0000000020","article-title":"Screening of blood donors for erythrocyte alloantibodies","volume":"17","author":"Pahuja","year":"2012","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib19","first-page":"EC12","article-title":"Erythrocyte alloimmunization and autoimmunization among blood donors and recipients visiting a tertiary care hospital","volume":"11","author":"Kaur","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/ajts.AJTS_4_17","article-title":"Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India","volume":"12","author":"Makroo","year":"2018","journal-title":"Asian J Transfus Sci"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/ajts.AJTS_118_19","article-title":"Prevalence of irregular red cell antibody in transfusion recipients vis-a-vis healthy blood donors attending a tertiary care hospital in North India","volume":"16","author":"Yadav","year":"2022","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2024.103963_bib22","article-title":"Anti-A and anti-B haemolysins amongst Group \u201cO\u201d voluntary blood donors in Northeastern Nigeria","volume":"2011","author":"Kagu","year":"2011","journal-title":"J Blood Transf"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/trf.15004","article-title":"Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III)","volume":"59","author":"Karafin","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000085740","article-title":"Frequency of red blood cell alloantibody in Kuwaiti population","volume":"14","author":"Ameen","year":"2005","journal-title":"Med Princ Pract"},{"issue":"2","key":"10.1016\/j.transci.2024.103963_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1423-0410.2011.01517.x","article-title":"Red-blood-cell alloimmunization and number of red-blood-cell transfusions","volume":"102","author":"Zalpuri","year":"2012","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib26","first-page":"630","article-title":"Screening analysis of irregular antibodies from random donor population in Shaoguan area.","volume":"15","author":"Zhu","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"6 Pt 2","key":"10.1016\/j.transci.2024.103963_bib27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/trf.13111","article-title":"Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusion","volume":"55","author":"Verduin","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2024.103963_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1590\/1516-3180.2015.00042302","article-title":"Hemoglobinopathies in newborns in the southern region of the Tri\u00e2ngulo Mineiro, Brazil. Cross-sectional study","volume":"133","author":"Carlos","year":"2015","journal-title":"Sao Paulo Med J"},{"issue":"6","key":"10.1016\/j.transci.2024.103963_bib29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1590\/S0102-311X2002000600036","article-title":"Screening program for hemoglobinopathies based on blood donors from Bragan\u00e7a Paulista, S\u00e3o Paulo, Brazil","volume":"18","author":"Acedo","year":"2002","journal-title":"Cad Saude Publica"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib30","first-page":"27","article-title":"Hemoglobinopatias: preval\u00eancia em doadores de sangue","volume":"5","author":"Valer","year":"2012","journal-title":"Rev Saude Pesq"},{"issue":"supl. 2","key":"10.1016\/j.transci.2024.103963_bib31","first-page":"142","article-title":"Preval\u00eancia e controle da hemoglobina S","volume":"22","author":"Naoum","year":"2000","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1590\/S1516-84842004000100006","article-title":"Freq\u00fc\u00eancia de hemolisinas anti-A e anti-B em doadores de sangue do Hemocentro de Botucatu","volume":"26","author":"Gambero","year":"2004","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib33","first-page":"224","article-title":"Frequency of high-titer hemolysins in O blood group donors: experience of S\u00e3o Jos\u00e9 dos Campos Hemotherapy Service","volume":"26","author":"Rosa","year":"2004","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5581\/1516-8484.20110073","article-title":"Titers of ABO antibodies in group O blood donors","volume":"33","author":"de Fran\u00e7a","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib35","first-page":"39","article-title":"High frequency of anti-A and anti-B haemolysins in certain ethnic groups of Nigeria","volume":"48","author":"Kulkarni","year":"1985","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib36","first-page":"319","article-title":"Prevalence and titre of alpha and beta haemolysins in blood group 'O' donors in Ilorin","volume":"30","author":"Olawumi","year":"2001","journal-title":"Afr J Med Med Sci"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib37","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.4102\/ajlm.v11i1.1432","article-title":"Prevalence of alpha and beta haemolysin among blood group O donors in Bamenda, Cameroon","volume":"11","author":"Fondoh","year":"2022","journal-title":"Afr J Lab Med"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1537-2995.2010.02759.x","article-title":"A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies","volume":"51","author":"Quillen","year":"2011","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21315\/mjms2023.30.4.6","article-title":"Characteristics of ABO antibodies in group O Malaysian blood donors","volume":"30","author":"Saidin","year":"2023","journal-title":"Malays J Med Sci"},{"issue":"7","key":"10.1016\/j.transci.2024.103963_bib40","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/trf.15273","article-title":"Immunoglobulin\u00a0M anti-A and anti-B titers in South Texas group O D+ male donors","volume":"59","author":"Beddard","year":"2019","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2024.103963_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcla.21499","article-title":"The characteristics of ABO antibodies in group O Thai blood donors","volume":"26","author":"Khampanon","year":"2012","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.transci.2024.103963_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21307\/immunohematology-2019-316","article-title":"Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations","volume":"23","author":"Mazda","year":"2007","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2024.103963_bib43","first-page":"125","article-title":"Haemolysin test for characterization of immune ABO antibodies","volume":"118","author":"Mathai","year":"2003","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.transci.2024.103963_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00394-009-0063-5","article-title":"Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status","volume":"49","author":"P\u00e9rez","year":"2010","journal-title":"Eur J Nutr"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:26:27Z","timestamp":1732256787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1473050224001319"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103963","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irregular red blood cell antibodies, abnormal hemoglobin and dangerous universal blood donor insights from a public blood center in a Brazilian metropolitan area","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103963"}}